Most medicines used to treat diabetes, including prescription medication and certain supplements, aim to lower blood glucose and blood sugar levels by regulating the body’s insulin use or glucose production. These diabetes treatments, prescribed by a healthcare provider, help reduce the risk of severe symptoms, long-term health problems, and cardiovascular complications of the chronic disease.
Exceptions such as insulin, Ozempic, exenatide, and pramlintide are administered via injection or inhalation rather than orally. Providers call these injectable therapies GLP-1 receptor agonists (GLP) that can produce significant weight loss effects and help reduce kidney and heart disease risks. Insulin, especially, plays a central role in both Type 1 and Type 2 diabetes care due to its versatility in adults and pregnant individuals, even under serious allergic conditions. These therapies support careful meal planning and food intake management to prevent hypoglycemia and stomach issues.
Prescription for Drug Alternatives
You would be wrong to assume, however, that there is just a single type of medication used to treat diabetes. In fact, there are several classes of these medicines, and the optimal treatment plan for a patient depends on the specific type of disease, personal health nuances—including thyroid or kidney conditions—and lifestyle factors.
A healthcare provider will evaluate risks, side effects, and any allergic reactions before recommending a therapy. Additionally, some drugs called GLP-1 receptor agonists have been approved by the FDA to help reduce blood sugar, enhance cardiovascular health, support weight loss, and lower the risk of heart disease or severe diabetic complications.
For example, insulin is a critical medication for Type 1 diabetes treatment, designed to compensate for the body’s inability to produce this hormone. Insulin therapy may involve subcutaneous injections, insulin pumps, or even inhalable insulin under FDA review to reduce caregiver procedures and minimize pain and side effects. Rapid advancements in diabetic care technology— including continuous glucose monitors—help people track real-time glucose changes, prevent severe hypoglycemia or nausea, and lower the risk of cardiovascular complications and complications at the kidney and heart level.
On the other hand, Type 2 diabetes occurs when the body cannot use insulin effectively, causing insulin resistance and high blood sugar. In these cases, diabetic care plans may include oral medicines, injectable therapies such as Ozempic or other GLP-1 agonists, and supplements to improve insulin sensitivity or stimulate pancreatic insulin release. For adults with comorbid heart or kidney disease, SGLT2 inhibitors—FDA-approved to reduce cardiovascular and renal risks—offer dual benefits, helping lower glucose levels, reduce blood pressure, and manage body weight without requiring surgery or invasive procedures.
There is more than one group of diabetes drugs commonly used for Type 2 diabetes, many of which are administered orally or in combination with injectable therapies to enhance blood sugar control. Treatment plans often include metformin—considered the first-line medication—and can be paired with DPP-4 inhibitors or alpha-glycosidase inhibitors, as well as supplements to mitigate stomach side effects. Before prescribing, healthcare providers assess patient history for thyroid issues, pregnancy status, and cardiovascular risk to reduce the chance of severe hypoglycemia or allergic reactions.
By using insulin in Type 2 diabetes care, patients can customize dosage based on real-time blood sugar and glucose readings with modern healthcare devices. Injectable medications called GLP-1 receptor agonists also leverage natural hormone pathways to improve glycemic control, help reduce appetite, support weight management, and provide cardiovascular protection. When combined in a comprehensive treatment plan—including diet, supplements, and lifestyle changes—this approach helps reduce the risk of severe complications, hospitalizations, and related procedures.
Of course, insulin remains the most widely prescribed diabetes medication for diabetic adults, called basal-bolus regimens, which can be delivered through injections, pumps, or inhalable devices pending FDA approval.
Innovations in diabetic care continue to reduce complications by offering basal long-acting insulins and ultra-rapid preparations that even out blood glucose fluctuations, lower the risk of hypoglycemia, and minimize the number of injections and medical procedures required for long-term stability.
Sulfonylureas, among the earliest oral hypoglycemic agents approved by the FDA, stimulate the pancreas to release insulin but can carry risks of hypoglycemia, weight gain, and gastrointestinal side effects like stomach pain or nausea. These diabetes medicines remain effective for many adults but require careful monitoring by healthcare providers to prevent severe reactions or cardiovascular problems.
Newer classes, such as meglitinides, work rapidly in response to food intake, allowing for flexible dosing and reducing the risk of low blood sugar and diabetic complications, including kidney damage or even death in extreme cases.
Another popular class of diabetes medicines is alpha-glycosidase inhibitors, which slow starch digestion in the stomach and intestines to prevent rapid glucose spikes after food intake. While not traditional hypoglycemic agents, they can help reduce postprandial blood sugar fluctuations without affecting thyroid function.
Healthcare providers may include these inhibitors in a broader treatment plan alongside dietary changes, supplements, and exercise to manage type 2 diabetes, although patients must watch for gastrointestinal side effects like gas, diarrhea, or severe abdominal pain.